结构-活性关系研究,使用西亚醇作为新型疫苗辅助剂
Masiel M Belsuzarri1, Yukiya Sako1, Tyler D Brown1
1UC San Diego Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
Journal of medicinal chemistry
|August 8, 2024
概括
研究人员探索化合物,通过促进细胞外囊泡 (EV) 释放来增强疫苗辅助剂. 结构-活性关系研究确定了关键的分子特征,验证了强大的新型疫苗辅助剂候选者.
科学领域:
- 免疫学和疫苗学 免疫学和疫苗学
- 生物化学和分子生物学
- 药物发现和开发 药物发现和开发
背景情况:
- 细胞外囊泡 (EVs) 对于抗原和免疫调节分子的转移至关重要.
- 来自具有免疫刺激功能的抗原呈现细胞的EV在疫苗配方中具有价值.
- 化合物634 (1) 此前已被确定可以增强EV释放和细胞内Ca2+流入.
研究的目的:
- 对化合物634 (1) 进行结构-活性关系 (SAR) 研究.
- 优化化合物以提高作为疫苗辅助剂的效力.
- 通过概念验证疫苗接种研究,验证选择的化合物作为新型疫苗辅助剂.
主要方法:
- 基于最初的脚手架合成了新的化合物.
- 在人体THP-1细胞中进行CD63记者活性 (EV生物发生标志物) 的体外分析.
- 在实验室分析小鼠骨髓衍生的树突细胞,检测Ca2+流入,IL-12产生和细胞活力.
主要成果:
- SAR研究表明,功能组对活性至关重要.
- 用 (9f) 或乙烯基组 (9h) 替换提亚二醇环的硫原子,维持了化合物的强度.
- 概念验证疫苗接种研究证实了优化化合物的辅助潜力.
结论:
- 系统的SAR研究成功优化了化合物634 (1) 的衍生物.
- 这些已识别的化合物显示出作为新型疫苗辅助剂的巨大潜力.
- 这些发现为开发更有效的疫苗配方铺平了道路.
更多相关视频
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
9.4K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.8K
相关概念视频
01:51Vaccinations
44.2K
Overview
44.2K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
01:28Structure-Activity Relationships and Drug Design
687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687